Novo Nordisk
NVO
#82
Rank
A$308.34 B
Marketcap
A$69.65
Share price
0.90%
Change (1 day)
-33.58%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): A$37.09 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$51.37 Billion. In 2025 the company made an earning of A$30.37 Billion, an increase over its 2024 earnings that were of A$28.57 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$37.09 B22.13%
2025 A$30.37 B6.28%
2024 A$28.57 B28.01%
2023 A$22.32 B57.81%
2022 A$14.14 B5.24%
2021 A$13.44 B12.38%
2020 A$11.96 B13.11%
2019 A$10.57 B-3.45%
2018 A$10.95 B1.88%
2017 A$10.75 B4.3%
2016 A$10.30 B10.32%
2015 A$9.34 B7.47%
2014 A$8.69 B3.4%
2013 A$8.40 B19.09%
2012 A$7.06 B15.58%
2011 A$6.10 B16.58%
2010 A$5.24 B25.66%
2009 A$4.17 B10.68%
2008 A$3.76 B55.82%
2007 A$2.41 B7.02%
2006 A$2.25 B19.05%
2005 A$1.89 B10.55%
2004 A$1.71 B
2002 A$1.16 B-14.39%
2001 A$1.36 B-52.82%
2000 A$2.89 B250%
1999 A$0.82 B31.21%
1998 A$0.63 B34.31%
1997 A$0.46 B11.46%
1996 A$0.42 B9.03%
1995 A$0.38 B-3.15%
1994 A$0.39 B-0.67%
1993 A$0.40 B45.38%
1992 A$0.27 B-13.81%
1991 A$0.32 B37.12%
1990 A$0.23 B-0.79%
1989 A$0.23 B26.2%
1988 A$0.18 B24.97%
1987 A$0.14 B-0.9%
1986 A$0.15 B-7.78%
1985 A$0.16 B24.87%
1984 A$0.13 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$15.34 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$45.10 B 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.09 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$13.90 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA